Trial Profile
A phase I trial of SNP-610
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs SNP 610 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions
- 20 Jul 2017 New trial record